PCR instrumentation and its isothermal amplification alternatives have evolved dramatically since COVID-19 elevated molecular diagnostic awareness globally, with the Laboratory Equipment Market reflecting the diverse molecular amplification equipment market beyond the pandemic-era RT-PCR surge toward digital PCR, multiplex syndromic panels, and CRISPR-based diagnostic platforms.

Digital PCR — partitioning samples into thousands of individual reaction chambers for absolute nucleic acid quantification without calibration curves — provides the quantitative precision and sensitivity that conventional real-time PCR's relative quantification approach cannot achieve for applications requiring absolute copy number determination. Rare mutation detection in liquid biopsy ctDNA, viral load quantification at very low copy numbers, and gene copy number variation analysis represent digital PCR's superior application domains. Biorad's QX200 and Stilla's Naica system provide the major commercial ddPCR platforms.

CRISPR diagnostic platforms — using Cas12 and Cas13 detection of specific nucleic acid sequences to generate fluorescent or visual signals — provide the specificity of oligonucleotide hybridization with signal amplification enabling sensitive lateral flow readout without thermal cycler requirements. Sherlock Biosciences and Mammoth Biosciences have developed CRISPR diagnostic platforms with potential advantages in specificity and ambient temperature operation for resource-limited settings.

Multiplex syndromic PCR panels — testing a single sample against twenty to forty pathogens simultaneously from respiratory, gastrointestinal, or CNS specimen types — have become standard of care at many hospitals, with the clinical value of knowing which specific pathogen from a differential outweighing the higher cost of multiplex versus single-pathogen PCR for acute care decision-making.

Do you think CRISPR-based diagnostics will achieve sufficient sensitivity and regulatory clearance to compete with PCR for molecular infectious disease testing in mainstream clinical laboratories?

FAQ

What is digital PCR and when is it used? Digital PCR partitions samples into thousands of individual reactions providing absolute nucleic acid quantification with higher precision and sensitivity than real-time PCR; it is used for rare mutation detection in liquid biopsy, low-copy viral load measurement, and gene dosage analysis.

What are CRISPR diagnostics? CRISPR diagnostics use engineered Cas proteins that detect specific DNA or RNA sequences and generate detectable signals, enabling highly specific molecular detection without thermal cycling at potentially lower cost and complexity than PCR-based approaches.

#LaboratoryEquipment #DigitalPCR #CRISPRdiagnostics #MolecularDiagnostics #PCRequipment #MultiplexPCR